1,803
Participants
Start Date
October 17, 2014
Primary Completion Date
November 9, 2018
Study Completion Date
November 9, 2018
Tolvaptan
Tolvaptan tablets (15 or 30 mg) self-administered orally as split-dose regimens, once upon awakening and another approximately 8 to 9 hours later
Budapest
Brussels
Brussels
Camperdown
St Leonards
Westmead
New Lambton Heights
Edegem
Leuven
Parkville
Reservoir
Richmond
Liège
Durban
Woolloongabba
Adelaide
Bergen
Junín
Perth
Szeged
Launceston
Holstebro
Pécs
Cape Town
Aarhus N
Kortrijk
Ghent
Aalborg
Aalst
New York
New York
Berlin
Laurelton
Mineola
Ciudad Real
Stockholm
Buffalo
Stockholm
Bethlehem
Doylestown
Philadelphia
Milan
Milan
Greenbelt
Rockville
Baltimore
Baltimore
Arlington
Charlottesville
Norfolk
Lecco
Montichiari
Morgantown
Pavia
Winston-Salem
Chapel Hill
Madrid
Madrid
Charlotte
Asheville
Orangeburg
Columbia
Charleston
Atlanta
Augusta
Jacksonville
Miami
Tampa
Port Charlotte
Ocala
Hudson
Birmingham
Huntsville
Mobile
Nashville
Nashville
Knoxville
Düsseldorf
Modena
Columbus
Cleveland
Akron
Essen
Cincinnati
Cincinnati
Valencia
Roseville
Detroit
Pontiac
Kalamazoo
Grand Rapids
Jilemnice
Ramat Gan
Rochester
Fargo
Linköping
Chicago
Chicago
St Louis
Wiesbaden
Kansas City
Wichita
Heidelberg
Bari
Baton Rouge
Uppsala
Arlington
Houston
Houston
Ashkelon
McAllen
Aurora
Napoli
Denver
Denver
Munich
Meridian
Tempe
Phoenix
Tucson
Las Vegas
Reno
Los Angeles
Los Angeles
Nuremberg
La Jolla
San Francisco
Stanford
Portland
Wenatchee
Yaroslavl
Saint Petersburg
Oradea
Petah Tikva
Kemerovo
Krasnoyarsk
Nahariya
Tel Aviv
Jerusalem
Saint Petersburg
New Haven
Boston
Springfield
Eatontown
Voorhees Township
Burlington
Ciudad Autonoma de Buenos Aires
Ciudad Autonoma de Buenos Aires
Ciudad Autonoma de Buenos Aires
Ciudad Autonoma de Buenos Aires
Pergamino
Pilar
Córdoba
Córdoba
Córdoba
Edmonton
Mount Pearl
Scarborough Village
Toronto
Toronto
Montreal
Brno
České Budějovice
Hradec Králové
Jihlava
Liberec
Ostrava
Prague
Prague
Dresden
Amsterdam
Groningen
Nijmegen
Ciechanów
Gdansk
Golub-Dobrzyń
Krakow
Lodz
Lodz
Lublin
Szczecin
Warsaw
Wroclaw
Bucharest
Bucharest
Bucharest
Pretoria
Barcelona
Gothenburg
Belfast
Exeter
Hull
Brighton
London
London
London
Manchester
Salford
Stevenage
Inverness
Leicester
Edinburgh
Liverpool
Sheffield
Stoke-on-Trent
Newcastle upon Tyne
Coventry
Birmingham
Middlesbrough
Swansea
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY